Board of Directors

Heru’s Board of Directors is comprised of esteemed physicians and executives with a wealth of experience in eye care, medical technology, and other industries.

Mohamed Abou Shousha, MD, FRCS, PhD Headshot

Mohamed Abou Shousha, MD, FRCS, PhD

Founder, President, Chief Executive Officer and Chairman of the Board

Mohamed Abou Shousha, MD, PhD is Heru’s President and Chief Executive Officer. Dr. Abou Shousha is a practicing ophthalmologist at the University of Miami’s Bascom Palmer Eye Institute, where he serves as Associate Professor of Clinical Ophthalmology, Electrical and Computer Engineering, and Biomedical Engineering.
Read Full Bio
He and his team of clinicians and engineers spent over ten years conducting clinical and scientific research of ophthalmic imaging and artificial intelligence (AI) algorithms that led to Heru AI powered wearable device. His work has been published in leading peer reviewed ophthalmology journals. In addition to other prestigious awards, Dr. Abou Shousha was awarded a K23 award from the National Eye Institute, the Stanley J. Glaser Award, the American Academy of Ophthalmology Achievement Award, Achievement Award of the Association of University Professor of Ophthalmology (AUPO) and the 6 Best Paper of Session award of the American Society of Cataract and Refractive Surgery (ASCRS).

Dr. Abou Shousha received his medical degree from the Faculty of Medicine, Alexandria University, Egypt and completed his residency at St. Louis University Eye Institute. He completed a fellowship in cornea, refractive surgery and external eye disease at the University of Miami, Bascom Palmer Eye Institute. He holds a doctoral degree in ophthalmology and vision sciences from the Supreme Council of Universities of Egypt.

Fred Drasner headshot

Fred Drasner

Board Member

Fred Drasner is presently Chairman of Three Seasons Capital, LLC, a venture capital firm. Mr. Drasner joined Shaw, Pittman, Potts and Trowbridge (now Pillsbury Winthrop Shaw Pittman) in 1972 as a tax lawyer and served as its principal Tax Partner until 1985. In 1985, Mr. Drasner, with a partner, acquired U. S. News &World Report and served as its CEO and Co-Chairman from 1985 to 2004.
Read Full Bio
In 1993, he handled the acquisition of the New York Daily News and remained co-owner, Chief Executive Officer and Co-Publisher until 2004.

Mr. Drasner founded Fast Company Magazine in 1995 and served as CEO until its sale 1999. In 1985, Mr. Drasner reorganized PPI (a subsidiary of U.S. News) into Applied Graphics Technologies, took it public in 1996 (NASDAQ), and served as its Chairman and CEO from 1985 until its sale in 2003. During that period, it grew into the world’s largest Digital Image Management company. Mr. Drasner also served as Chairman of Applied Printing Technologies, a sister company to Applied Graphics, from 1985 to 2003. Mr. Drasner was one of the initial investors in Snyder Communications (NYSE) and a board member until its sale to Havas for $2.3 billion in 1999. He was co-owner and Vice Chairman of The Washington Redskins football team from 1999 to 2004. Mr. Drasner served as a member of the Board of Directors of Ventiv Health, Inc. (now inVentiv Health Inc. NASDAQ); Applied Graphics Technologies (NASDAQ); Snyder Communications (NYSE) and the Washington Redskins. Mr. Drasner was one of the founders of the Vehicle Production Group in 2007 and served as its Chairman until its sale in 2013.

Mr. Drasner has a B.S. degree from New York University, a J.D. degree from American University, Washington College of Law, and an LLM in Taxation from New York University School of Law.

Maurice R. Ferré, MD headshot

Maurice R. Ferré, MD

Board Member

Maurice Ferré, MD is a seasoned serial entrepreneur in the medical technology industry. Dr. Ferré is currently Chief Executive Officer and Chairman of the Board at INSIGHTEC, the innovator of incisionless surgery. Prior to this, Dr. Ferré, served as Chief Executive Officer and Chairman of the Board of MAKO Surgical Corporation, a robotic surgical company that he co-founded.
Read Full Bio
In 2013, the company was acquired by Stryker Corp. for $1.65 billion. He also served as Founder, Chief Executive Officer and President of Visualization Technology Inc. (VTI) which became the world leader in image guided surgery for ENT, cranial and orthopedics procedures before the company was acquired by GE Healthcare. Dr. Ferré was the recipient of the prestigious Ernest and Young Entrepreneur of the Year Award in 2007 and 2020. He was also awarded Bio-Florida’s Lifetime Achievement Award in 2018.

Dr. Ferré received his medical degree and a master’s degree in public health from Boston University.

Richard K. Parrish II, MD headshot

Richard K. Parrish II, MD

Board Member

Richard K. Parrish II, MD is a world-renowned glaucoma specialist and is the Edward W.D. Norton Chair in Ophthalmology and Associate Dean for Graduate Medical Education at the University of Miami Miller School of Medicine. He also serves as Chairman of the Graduate Medical Education Committee and is the designated institutional representative for the Jackson Health System/Jackson Memorial Hospital.
Read Full Bio
Dr. Parrish has published over 100 peer reviewed scientific publications and is an international speaker. Dr. Parrish is currently Editor-in-Chief of the American Journal of Ophthalmology. He also served as Editor of Transactions of the American Ophthalmological Society and was previously an Associate Editor for the Brief Reports section and Executive Editor of the Glaucoma section for the American Journal of Ophthalmology and edited Bascom Palmer Eye Institute’s Atlas of Ophthalmology. Dr. Parrish is Vice Chair and a principal investigator of the National Eye Institute (NEI)-sponsored Ocular Hypertension Treatment Study (OHTS) Phase 3 and Principal Investigator of the OHTS Optic Disc Reading Center.

Dr. Parrish has a medical degree from Indiana University School of Medicine and served his internship at the University of Alabama School of Medicine. He completed a residency in ophthalmology at Wills Eye Hospital and conducted a clinical and research glaucoma fellowship at Bascom Palmer Eye Institute.

Rajesh Rajpal, MD headshot

Rajesh Rajpal, MD

Board Member

Rajesh Rajpal, MD is the Founder of See Clearly Vision, a group practice in the Washington, DC area. He previously served as Chief Medical Officer for Avedro (acquired by Glaukos) and is Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision.
Read Full Bio
Dr. Rajpal currently holds appointments on the clinical faculties of Georgetown University Medical Center and Virginia Commonwealth University and serves as the Cornea Consultant to the Walter Reed National Military Medical Center. He is certified by and a Diplomate of the American Board of Ophthalmology, and a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, Cedars/Aspens, AECOS, and the International Society of Refractive Surgery. Dr. Rajpal also served as President and on the Board of Directors of the Washington D.C. Ophthalmology Society. He served as the principal investigator in numerous clinical trials, authored multiple original peer reviewed publications, and lectured internationally on topics related to corneal disease, cataract and refractive surgery. In addition to other awards, Dr. Rajpal is a recipient of the Senior Achievement and Secretariat awards from the American Academy of Ophthalmology.

Dr. Rajpal received his medical degree from the Virginia Commonwealth University School of Medicine and conducted a fellowship in cornea and external disease at Wills Eye Hospital.

Christopher C. Dewey headshot

Christopher C. Dewey

Board Observer

Christopher C. Dewey currently serves as a Managing Director of Ceros Financial Services, Inc. He was a Founder and President of The Cannon Group Inc, a/k/a Cannon Films, the first independent film company to finance, produce and distribute motion pictures worldwide. Cannon became a public company in 1972 and was thereafter sold.
Read Full Bio
He was a Partner and Institutional Sales Manager of high yield corporate bonds at Bear, Stearns & Co. Inc., from 1980 to 1990. In 1990 he joined Scully Brothers & Foss/The Marion Group, L.P. as Managing Partner where he remained until 1994. Mr. Dewey was Executive Vice President and Head of high yield sales at Jefferies & Company, Inc. from 1994 until 2007. While at Jefferies, he developed a business with partners, Bonds Direct, which Jefferies purchased, and a venture fund called Robotics Ventures. He held the position of Vice Chairman of the Board at National Securities Corporation from 2007 until 2011. Mr. Dewey was a founding board member of Mako Surgical, and he served on both the audit and compensation committees when the company went public until its sale to Stryker Corp. in 2013.

Mr. Dewey has been a founding investor and board member of many successful startups, including Auris Surgical Corp, which was sold to Johnson & Johnson in 2019, Procept BioRobotics, ShockWave Medical, which went public in 2019, OrthoSensor, DermaSensor, Amerinac Holdings, Cephea Valve Technologies, which was sold to Abbot Labs in 2019, GI Windows, HistoSonics, Inc., Insightec Ltd., Magic Leap, Me-mic Innovative Surgery, Inc., MIVI Neuroscience Inc., Triflow Cardiovascular, Inc., Potrero Medical Inc., and Pristine Surgical, LLC.

Mr. Dewey has served as a Managing Director of Ceros Financial Services, Inc. since June 2019. Mr. Dewey holds an M.B.A. from The Wharton Graduate School, 1987.